Benzinga - Tue, 09 Mar 2021 06:03:09 -0400
Benzinga - Mon, 08 Mar 2021 13:54:59 -0400
Benzinga - Mon, 08 Mar 2021 09:12:19 -0400
Benzinga - Mon, 08 Mar 2021 06:08:58 -0400
Benzinga - Fri, 05 Mar 2021 17:39:36 -0400
Benzinga - Fri, 05 Mar 2021 13:47:47 -0400
Benzinga - Fri, 05 Mar 2021 13:02:17 -0400
Benzinga - Fri, 05 Mar 2021 12:57:57 -0400
Benzinga - Fri, 05 Mar 2021 11:32:29 -0400
Benzinga - Fri, 05 Mar 2021 09:13:03 -0400
Benzinga - Fri, 05 Mar 2021 07:58:08 -0400
load more
XTL Biopharmaceuticals Ltd is engaged in the field of healthcare. It is a pharmaceutical manufacturer, with a focus on acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
XTLBXTL Biopharmaceuticals-1.54%16.5M

XTL Biopharmaceuticals Company Questions & Answers

Q

How do I buy XTL Biopharmaceuticals (XTLB) stock?

A

You can purchase shares of XTL Biopharmaceuticals (NASDAQ: XTLB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are XTL Biopharmaceuticals's (XTLB) main competitors?

A

There are no as such competitors for XTL Biopharmaceuticals.

Q

What is the target price for XTL Biopharmaceuticals?

A

The latest price target for XTL Biopharmaceuticals (NASDAQ: XTLB) was reported by H.C. Wainwright on 2015-05-08. The analyst firm set a price target for 6.00 expecting XTLB to rise to within 12 months (a possible 87.50% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is XTL Biopharmaceuticals (XTLB) stock ?

A

The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $3.2 last updated Today at 8:00:02 PM.

Q

When is the next XTL Biopharmaceuticals (XTLB) dividend?

A

There are no upcoming dividends for XTL Biopharmaceuticals.

Q

When is XTL Biopharmaceuticals (NASDAQ:XTLB) reporting earnings?

A

There are no earnings for XTL Biopharmaceuticals

Q

When is the upcoming split for XTLB?

A

There is no upcoming split for XTL Biopharmaceuticals.